Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

for
Depressive Disorder, Major
Location: Washington D.C. DC, Baltimore MD, Chapel Hill NC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 12 - 17

Code: NCT07227454

Phase 3, Recruiting

Characterization of Acute Pain

for
Acute Pain, Postoperative, Postoperative Pain, Acute Pain
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 6 - 21

Code: NCT07336264

Recruiting

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Washington D.C. DC, Baltimore MD, Hackensack NJ,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 25

Code: NCT07110246

Phase 2, Recruiting

Combatting HIV Or Other STIs Early (CHOOSE)

for
HIV, STIs, STIs Prevention, HIV Prevention
Location: Washington D.C. DC, Chicago IL, Memphis TN, Tampa FL,
Sponsor: Westat

Sex: Male

Age: 13 - 24

Code: NCT07510048

Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Washington D.C. DC, Toronto, Montreal, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT04901702

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Washington D.C. DC, Baltimore MD, King of Prussia PA,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Washington D.C. DC, Philadelphia PA, Hackensack NJ,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase 3, Recruiting

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

for
Medulloblastoma, Medulloblastoma, Childhood,
Location: Washington D.C. DC, Seattle WA
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 1 - 25

Code: NCT07346157

Phase 1, Phase 2, Recruiting

Empowering Young Parents: Building Healthy Relationships Study

for
Gender-based Violence, Intimate Partner Violence
Location: Washington D.C. DC, Camden DE, Georgetown DE,
Sponsor: RTI International

Sex: Female

Age: 14 - 21

Code: NCT06576193

Recruiting

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

for
Allergic Reactions
Location: Washington D.C. DC, New York NY, Cincinnati OH,
Sponsor: ARS Pharmaceuticals, Inc.

Sex: All

Age: 4+

Code: NCT06834165

Recruiting

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

for
Duchene Muscular Dystrophy
Location: Washington D.C. DC, New York NY, Durham NC,
Sponsor: ITF Therapeutics LLC

Sex: All

Age: 6+

Code: NCT07127978

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome

for
Short Bowel Syndrome
Location: Washington D.C. DC, Boston MA, Cincinnati OH,
Sponsor: Eclipse Regenesis, Inc.

Sex: All

Age: 0 - 65

Code: NCT05535361

Recruiting

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 1 - 8

Code: NCT06188741

Phase 2, Recruiting

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

for
Severe Alopecia Areata
Location: Washington D.C. DC, Hershey PA, Waterford MI,
Sponsor: Pfizer

Sex: All

Age: 6 - 14

Code: NCT07029828

Phase 3, Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 39

Code: NCT04616560

Phase 2, Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

for
Duchenne Muscular Dystrophy (DMD), Cardiomyopathy,
Location: Washington D.C. DC, Richmond VA, Durham NC, Columbus OH,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 0+

Code: NCT07674758

Recruiting

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

for
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG,
Location: Washington D.C. DC, Columbus OH, Toronto, Cincinnati OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT06838676

Phase 2, Recruiting

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

for
Heterozygous Familial Hypercholesterolemia (HeFH)
Location: Washington D.C. DC, Wilmington DE, Morgantown WV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 6 - 17

Code: NCT07058077

Phase 2, Phase 3, Recruiting